Literature DB >> 16720461

Skewed X inactivation in healthy individuals and in different diseases.

Karen Helene Ørstavik1.   

Abstract

UNLABELLED: In female mammalian cells, one of the two X chromosomes is inactivated in early embryonic life. Females are mosaics for two cell populations, one with the maternal and one with the paternal X as the active chromosome. Skewed X inactivation is arbitrarily defined, often as a pattern where 80% or more of the cells show a preferential inactivation of one X chromosome. Inactivation is presumed to be permanent for all descendants of a cell; however, after about 55 years of age, the frequency of skewed X inactivation in peripheral blood cells increases, probably through selection. Unfavourable skewing of X inactivation, where the X chromosome carrying a mutant allele is the predominantly active X, has been found in affected female carriers of several X-linked disorders; however, for many X-linked disorders, a consistent relationship between the pattern of X inactivation and clinical phenotype has been difficult to demonstrate. One reason for this may be that peripheral blood cells are not a representative or relevant tissue in many disorders. In some severe X-linked disorders, post-inactivation selection takes place against the X chromosome carrying the mutant allele, leading to a completely skewed X-inactivation pattern. Skewed X inactivation has also been reported in young females with breast cancer, and may indicate an effect of X-linked genes on the development of this condition.
CONCLUSION: The process of X inactivation and the resultant degree of skewing is clearly important for the expression of genetic diseases. It is also important to consider, however, that under normal conditions the frequency of skewed X inactivation increases with age in peripheral blood cells. Analysis of the expression of a large proportion of the genes on the X chromosome has revealed that X-chromosome inactivation is more heterogeneous than previously thought.

Entities:  

Mesh:

Year:  2006        PMID: 16720461     DOI: 10.1080/08035320600618783

Source DB:  PubMed          Journal:  Acta Paediatr Suppl        ISSN: 0803-5326


  13 in total

1.  IL1RAPL1 gene deletion as a cause of X-linked intellectual disability and dysmorphic features.

Authors:  Erin L Youngs; Rebecca Henkhaus; Jessica A Hellings; Merlin G Butler
Journal:  Eur J Med Genet       Date:  2011-09-10       Impact factor: 2.708

Review 2.  X chromosome inactivation in clinical practice.

Authors:  Karen Helene Orstavik
Journal:  Hum Genet       Date:  2009-04-25       Impact factor: 4.132

3.  Effect of single-nucleotide polymorphisms of the 5' untranslated region of the human α-galactosidase gene on enzyme activity, and their frequencies in Portuguese caucasians.

Authors:  J P Oliveira; S Ferreira; J Barceló; P Gaspar; F Carvalho; M C Sá Miranda; J-E Månsson
Journal:  J Inherit Metab Dis       Date:  2008-11-03       Impact factor: 4.982

4.  X chromosome inactivation in women with alcoholism.

Authors:  Ann M Manzardo; Rebecca Henkhaus; Brandon Hidaka; Elizabeth C Penick; Albert B Poje; Merlin G Butler
Journal:  Alcohol Clin Exp Res       Date:  2012-02-29       Impact factor: 3.455

Review 5.  Deciphering the Role of the Barr Body in Malignancy: An insight into head and neck cancer.

Authors:  Deepti Sharma; George Koshy; Shruti Gupta; Bhushan Sharma; Sonal Grover
Journal:  Sultan Qaboos Univ Med J       Date:  2018-01-10

Review 6.  Dosage Compensation in Females with X-Linked Metabolic Disorders.

Authors:  Patrycja Juchniewicz; Ewa Piotrowska; Anna Kloska; Magdalena Podlacha; Jagoda Mantej; Grzegorz Węgrzyn; Stefan Tukaj; Joanna Jakóbkiewicz-Banecka
Journal:  Int J Mol Sci       Date:  2021-04-26       Impact factor: 5.923

7.  X inactivation in females with X-linked Charcot-Marie-Tooth disease.

Authors:  Sinéad M Murphy; Richard Ovens; James Polke; Carly E Siskind; Matilde Laurà; Karen Bull; Gita Ramdharry; Henry Houlden; Raymond P J Murphy; Michael E Shy; Mary M Reilly
Journal:  Neuromuscul Disord       Date:  2012-04-06       Impact factor: 4.296

Review 8.  Instability in X chromosome inactivation patterns in AMD: a new risk factor?

Authors:  Bajic Vladan; Spremo-Potparevic Biljana; Vesna Mandusic; Milicevic Zorana; Lada Zivkovic
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2013

9.  X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers.

Authors:  Isabella Garagiola; Mimosa Mortarino; Simona Maria Siboni; Marco Boscarino; Maria Elisa Mancuso; Marina Biganzoli; Elena Santagostino; Flora Peyvandi
Journal:  Eur J Hum Genet       Date:  2020-10-20       Impact factor: 4.246

10.  Skewed X-chromosome inactivation in patients with esophageal carcinoma.

Authors:  Gang Li; Tianbo Jin; Hongjuan Liang; Yanyang Tu; Wei Zhang; Li Gong; Qin Su; Guodong Gao
Journal:  Diagn Pathol       Date:  2013-04-04       Impact factor: 2.644

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.